Metabolic Tumor Volume as a Prognostic Imaging-Based Biomarker for Head-and-Neck Cancer
04/09/15 Portland, Ore.
Pilot Results From Radiation Therapy Oncology Group Protocol 0522
Metabolic Tumor Volume as a Prognostic Imaging-Based Biomarker for Head-and-Neck Cancer: Pilot Results From Radiation Therapy Oncology Group Protocol 0522David L. Schwartz,MD, Jonathan Harris,MS, Min Yao,MD,PhD, David I. Rosenthal,MD,FACR, Adam Opanowski,CNMT,PET,NCT,RT, Anthony Levering, RT(R)(CT)(MR),CIIP, K. Kian Ang,MD,PhD, Andy M. Trotti,MD, Adam S. Garden,MD, FASTRO, Christopher U. Jones,MD,FACR, Paul Harari, MD, Robert Foote,MD,FASTRO, John Holland, MD, Qiang Zhang,MD, PhD, Quynh-Thu Le,MD,FASTRO